Intech Investment Management LLC Buys Shares of 115,214 Envista Holdings Corporation $NVST

Intech Investment Management LLC bought a new stake in shares of Envista Holdings Corporation (NYSE:NVST) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund bought 115,214 shares of the company’s stock, valued at approximately $2,501,000.

A number of other large investors have also made changes to their positions in NVST. Royal Bank of Canada increased its position in shares of Envista by 26.6% in the 1st quarter. Royal Bank of Canada now owns 23,240 shares of the company’s stock valued at $401,000 after buying an additional 4,885 shares in the last quarter. Millennium Management LLC grew its stake in Envista by 218.6% in the first quarter. Millennium Management LLC now owns 383,966 shares of the company’s stock valued at $6,627,000 after purchasing an additional 263,442 shares in the last quarter. Goldman Sachs Group Inc. grew its stake in Envista by 39.3% in the first quarter. Goldman Sachs Group Inc. now owns 629,140 shares of the company’s stock valued at $10,859,000 after purchasing an additional 177,630 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Envista by 15.5% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 568,982 shares of the company’s stock valued at $9,821,000 after purchasing an additional 76,246 shares during the last quarter. Finally, Prudential Financial Inc. lifted its stake in Envista by 22.1% in the 2nd quarter. Prudential Financial Inc. now owns 18,785 shares of the company’s stock valued at $367,000 after purchasing an additional 3,395 shares during the last quarter.

Analyst Ratings Changes

Several brokerages have issued reports on NVST. Mizuho raised their price objective on shares of Envista from $24.00 to $27.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 10th. Wells Fargo & Company raised their target price on shares of Envista from $21.00 to $26.00 and gave the stock an “equal weight” rating in a report on Friday, February 6th. Weiss Ratings cut shares of Envista from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. Piper Sandler reaffirmed a “neutral” rating and set a $25.00 target price (up from $21.00) on shares of Envista in a report on Friday, February 6th. Finally, Leerink Partners set a $35.00 target price on shares of Envista and gave the stock an “outperform” rating in a report on Friday, February 6th. Six analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $28.83.

Envista Stock Performance

Shares of NYSE:NVST opened at $22.91 on Wednesday. The company’s 50 day simple moving average is $25.36 and its 200 day simple moving average is $24.49. The stock has a market capitalization of $3.73 billion, a price-to-earnings ratio of 55.87, a price-to-earnings-growth ratio of 1.46 and a beta of 0.88. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.44 and a quick ratio of 2.06. Envista Holdings Corporation has a 1 year low of $17.91 and a 1 year high of $30.42.

Envista (NYSE:NVST) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $0.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.31 by $0.05. Envista had a net margin of 2.41% and a return on equity of 7.11%. Envista’s revenue was up 14.4% on a year-over-year basis. During the same period in the previous year, the business earned $0.24 EPS. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. As a group, research analysts predict that Envista Holdings Corporation will post 1.43 EPS for the current fiscal year.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.